The FDA approved ensartinib for certain patients with locally advanced or metastatic non-small cell lung cancer. The U.S. Food and Drug Administration (FDA) has approved ensartinib (Ensacove) for adults with non-small cell lung cancer...
Researchers at the 2024 San Antonio Breast Cancer Symposium discussed considerations for treating and managing of early-onset breast cancer.
Chest radiation may not be necessary for people with intermediate-risk breast cancer.
Active surveillance of DCIS patients may be an alternative to treatment, and guidelines add self-test for HPV.
The FDA approved cosibelimab-ipdl for certain skin cancers that cannot be treated with surgery or radiation. The U.S. Food and Drug Administration (FDA) has approved cosibelimab-ipdl (Unloxcyt) for the treatment of adult patients with...
Research finds certain people with low-risk DCIS may be able to forgo surgery or radiation.
Data from clinical trials presented at SABCS may help patients with DCIS make informed choices between different management strategies.
The Black TNBC Sanctuary is a resource that provides key information and resources specifically for Black patients with TNBC.
HPV vaccine credited for decrease in cervical cancer deaths among young women, and new technology extends survival in locally advanced pancreatic cancer.
The FDA approved durvalumab for some patients with previously treated limited-stage small cell lung cancer. The U.S. Food and Drug Administration (FDA) has approved durvalumab (Imfinzi) for the treatment of adults with limited-stage...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More